UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

Journal of dermatology, 2024-10, Vol.51 (10), p.e349-e349

Zheng, Jiangling

2024

Volltextzugriff (PDF)

Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial

Journal of the American Academy of Dermatology, 2024-08

2024

Volltextzugriff (PDF)

Wound behavior in dystrophic epidermolysis bullosa: A retrospective natural history case series

Journal of the American Academy of Dermatology, 2024-07

2024

Volltextzugriff (PDF)

Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study

Journal of the American Academy of Dermatology, 2024-07, Vol.91 (1), p.82-90

2024

Volltextzugriff (PDF)

A case of anti‐laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase‐4 inhibitor administration

Journal of dermatology, 2024-06, Vol.51 (6), p.869-872

2024

Volltextzugriff (PDF)

Granular C3 dermatosis-A report of two cases and a mini-review of literature

Journal of dermatology, 2024-05

2024

Volltextzugriff (PDF)

Anterior chamber intraocular lens removal combined with triple DMEK: Quadruple DMEK for bullous keratopathy

European journal of ophthalmology, 2024-05, Vol.34 (3), p.NP13-NP17

2024

Volltextzugriff (PDF)

Risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

Journal of dermatology, 2024-04, Vol.51 (4), p.597-601

2024

Volltextzugriff (PDF)

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2

Proceedings of the National Academy of Sciences - PNAS, 2024-03, Vol.121 (12), p.e2312404121

2024

Volltextzugriff (PDF)

Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study

Journal of dermatology, 2024-03, Vol.51 (3), p.403-408

2024

Volltextzugriff (PDF)

Bullous pemphigoid following hand, foot, and mouth disease

Journal of dermatology, 2024-03, Vol.51 (3), p.e68-e69

2024

Volltextzugriff (PDF)

Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation

Proceedings of the National Academy of Sciences - PNAS, 2024-02, Vol.121 (6), p.e2309243121

2024

Volltextzugriff (PDF)

Cutaneous toxicity with subepidermal blisters and dyskeratosis following administration of pemetrexed in a patient with nivolumab‐induced psoriasis and linear IgA bullous dermatosis

Journal of dermatology, 2024-02, Vol.51 (2), p.e57-e58

2024

Volltextzugriff (PDF)

Solid and hematological malignancies in patients with bullous pemphigoid: A national cohort study

Journal of the American Academy of Dermatology, 2024-02, Vol.90 (2), p.399-401

2024

Volltextzugriff (PDF)

Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid

JAMA dermatology (Chicago, Ill.), 2024-01, Vol.160 (1), p.107

2024

Volltextzugriff (PDF)

Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study

Journal of the American Academy of Dermatology, 2024-01, Vol.90 (1), p.204-208

2024

Volltextzugriff (PDF)

Durability of long-term immunomodulating medications in the treatment of bullous pemphigoid

Journal of the American Academy of Dermatology, 2023-12, Vol.89 (6), p.1287-1289

2023

Volltextzugriff (PDF)

Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population‐based cohort study

Journal of dermatology, 2023-12, Vol.50 (12), p.1568-1575

2023

Volltextzugriff (PDF)

Skin-Related Quality of Life During Autoimmune Bullous Disease Course

JAMA dermatology (Chicago, Ill.), 2023-11, Vol.159 (11), p.1185

2023

Volltextzugriff (PDF)

Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China

Journal of dermatology, 2023-11, Vol.50 (11), p.1433-1441

2023

Volltextzugriff (PDF)

Simultaneous development of generalized pustular psoriasis and pemphigoid with multiple autoantibodies in a complete responder of pembrolizumab for lung cancer

Journal of dermatology, 2023-10, Vol.50 (10), p.1343-1346

2023

Volltextzugriff (PDF)

Psychological morbidity in patients with pemphigus and its clinicodemographic risk factor: A comparative study

Journal of dermatology, 2023-10, Vol.50 (10), p.1237-1245

2023

Volltextzugriff (PDF)

Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti‐p200 pemphigoid

Journal of dermatology, 2023-09, Vol.50 (9), p.1194-1198

2023

Volltextzugriff (PDF)

Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID‐19 messenger RNA vaccination

Journal of dermatology, 2023-09, Vol.50 (9), p.1190-1193

2023

Volltextzugriff (PDF)

A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma

Journal of dermatology, 2023-09, Vol.50 (9), p.1199-1202

2023

Volltextzugriff (PDF)

1 – 25 von 2.056

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.601)
Mit Volltextzugriff
(1.191)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

NUS Single-Journal Subscriptions
(2.056)
MEDLINE
(1.843)
Journals@Ovid
(1.454)
Ingenta
(798)
Elsevier ScienceDirect Journals
(767)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(680)
EZB Electronic Journals Library
(399)
IngentaConnect Journals
(304)
SpringerLink E-Journals
(281)
Wiley Online Library Journals
(185)
Wiley Online Library
(163)
SAGE Journals
(50)
Oxford Journals
(40)
JSTOR
(40)
Oxford Journals 2020 Medicine
(37)
BMJ_英国医学会期刊
(32)
BSC - Ebsco (Business Source Ultimate)
(20)
Psychology & Behavioral Sciences Collection (EBSCO)
(20)
Nexis Uni
(15)
Springer Nature - Connect here FIRST to enable access
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

Efficacy and safety of low-dose interleukin 2 in the treatment of moderate-to-severe bullous pemphigoid: A single center perspective-controlled trial

Wound behavior in dystrophic epidermolysis bullosa: A retrospective natural history case series

Autoimmune blistering disorders and cardiovascular risks: A population-based cohort study

A case of anti‐laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase‐4 inhibitor administration

Granular C3 dermatosis-A report of two cases and a mini-review of literature

Anterior chamber intraocular lens removal combined with triple DMEK: Quadruple DMEK for bullous keratopathy

Risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2

Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study

Bullous pemphigoid following hand, foot, and mouth disease

Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation

Cutaneous toxicity with subepidermal blisters and dyskeratosis following administration of pemetrexed in a patient with nivolumab‐induced psoriasis and linear IgA bullous dermatosis

Solid and hematological malignancies in patients with bullous pemphigoid: A national cohort study

Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid

Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study

Durability of long-term immunomodulating medications in the treatment of bullous pemphigoid

Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population‐based cohort study

Skin-Related Quality of Life During Autoimmune Bullous Disease Course

Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China

Simultaneous development of generalized pustular psoriasis and pemphigoid with multiple autoantibodies in a complete responder of pembrolizumab for lung cancer

Psychological morbidity in patients with pemphigus and its clinicodemographic risk factor: A comparative study

Usefulness of immunofluorescence overlay antigen mapping in the identification of autoantigen in anti‐p200 pemphigoid

Rapidly progressing generalized bullous fixed drug eruption after the first dose of COVID‐19 messenger RNA vaccination

A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma

Aktive Filter

Suchergebnisse filtern